Status:
COMPLETED
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Brain and Central Nervous System Tumors
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how pati...
Detailed Description
OBJECTIVES: Primary * Identify molecular characteristics that predict for overall survival and progression-free survival of patients treated with erlotinib hydrochloride, temozolomide, and radiother...
Eligibility Criteria
Inclusion
- All patients entered onto N0177 and N0074 who have appropriate archived clinical specimens.
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00897663
Start Date
November 1 2006
End Date
January 1 2018
Last Update
January 24 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States, 85259-5499
2
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States, 32224
3
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa, United States, 51101
4
Mercy Medical Center - Sioux City
Sioux City, Iowa, United States, 51102